Alzheimer’s clinical trial reaches halfway mark for enrollment

PROVIDENCE – Rhode Island Hospital is recruiting local participants for an international clinical trial to test an investigational drug intervention that may reduce the risk and development of Alzheimer’s disease. The Anti-Amyloid Treatment in Asymptomatic Alzheimer’s Disease, colloquially called A4, clinical trial is for individuals ages 65 to 85 who may be at risk for…

Want More?

Subscribe or register with Providence Business News to keep reading.

for 2 more stories

Subscribe now for $1 for 4 weeks
Already a Subscriber? Login now

Purchase NowWant to share this story? Click Here to purchase a link that allows anyone to read it on any device whether or not they are a subscriber.

- Advertisement -

No posts to display